TY - JOUR
T1 - Effect of endothelin-3 on cytosolic calcium level in vascular endothelium and on smooth muscle contraction
AU - Sudjarwo, Sri Agus
AU - Hori, Masatoshi
AU - Karaki, Hideaki
N1 - Funding Information:
We are grateful to Dr. T. Okada, International Research laboratories, CIBA-GEIGY Japan, for the generous gift of IRL 1038 and BQI23. This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture, Japan.
PY - 1992/12/15
Y1 - 1992/12/15
N2 - In isolated rat aorta, endothelin (ET)-3 increased cytosolic Ca2+ ([Ca2+]i) in the endothelium at a concentration (100 nM) which had little effect on muscle resting tone. In the absence of external Ca2+, ET-3 still transiently increased endothelial [Ca2+]i. Verapamil (10 μM) did not change the effects of ET-3. In aortas stimulated with 100 nM norepinephrine, 100 nM ET-3 relaxed the muscle with an increase in endothelial [Ca2+]i. An inhibitor of nitric oxide synthase, 100 μM NG-monomethyl-L-arginine, inhibited the relaxant effect of ET-3 but not the increase in endothelial [Ca2+]i. In the absence of the endothelium or in the presence of an antagonist of ETB receptors, 3 μM IRL 1038, the ET-3-induced increase in endothelial [Ca2+]i and relaxation of norepinephrine-induced contraction were inhibited. Under these conditions, ET-3 increased smooth muscle [Ca2+]i and induced contraction, both of which were inhibited by an inhibitor of ETA receptors, 3 μM BQ123. These results suggest that ET-3 acts on ETB receptors in the vascular endothelium to increase [Ca2+]i by releasing Ca2+ from storage sites and by opening non-L type Ca2+ channels, activates nitric oxide synthase, releases nitric oxide and relaxes vascular smooth muscle. Although ET-3 also activates ETA receptors in smooth muscle to induce contraction, this effect is overcome by the relaxant effect mediated by ETB receptors.
AB - In isolated rat aorta, endothelin (ET)-3 increased cytosolic Ca2+ ([Ca2+]i) in the endothelium at a concentration (100 nM) which had little effect on muscle resting tone. In the absence of external Ca2+, ET-3 still transiently increased endothelial [Ca2+]i. Verapamil (10 μM) did not change the effects of ET-3. In aortas stimulated with 100 nM norepinephrine, 100 nM ET-3 relaxed the muscle with an increase in endothelial [Ca2+]i. An inhibitor of nitric oxide synthase, 100 μM NG-monomethyl-L-arginine, inhibited the relaxant effect of ET-3 but not the increase in endothelial [Ca2+]i. In the absence of the endothelium or in the presence of an antagonist of ETB receptors, 3 μM IRL 1038, the ET-3-induced increase in endothelial [Ca2+]i and relaxation of norepinephrine-induced contraction were inhibited. Under these conditions, ET-3 increased smooth muscle [Ca2+]i and induced contraction, both of which were inhibited by an inhibitor of ETA receptors, 3 μM BQ123. These results suggest that ET-3 acts on ETB receptors in the vascular endothelium to increase [Ca2+]i by releasing Ca2+ from storage sites and by opening non-L type Ca2+ channels, activates nitric oxide synthase, releases nitric oxide and relaxes vascular smooth muscle. Although ET-3 also activates ETA receptors in smooth muscle to induce contraction, this effect is overcome by the relaxant effect mediated by ETB receptors.
KW - (Relaxation)
KW - (rat aorta)
KW - Ca levels (cytosolic)
KW - ET receptors
KW - Endothelin-3
KW - Endothelium-dependent relaxation
KW - Vascular
UR - http://www.scopus.com/inward/record.url?scp=0027049752&partnerID=8YFLogxK
U2 - 10.1016/0014-2999(92)90547-H
DO - 10.1016/0014-2999(92)90547-H
M3 - Article
C2 - 1490517
AN - SCOPUS:0027049752
SN - 0014-2999
VL - 229
SP - 137
EP - 142
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 2-3
ER -